Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Strategic Investment

23 Aug 2006 07:00

Embargoed Release: 07:00hrs Wednesday 23 August 2006 Nanoscience Inc. (`Nanoscience' or the `Group') Strategic Investment Nanoscience, the specialist nanotechnology investment holding company, ispleased to announce that it has completed its fourth strategic technologyinvestment since listing on AIM in March of last year. Nanoscience has investeda further SEK 927,996 (approximately ‚£68,000) in consideration for the issue of154,666 ordinary shares in AppliedSensor Sweden AB (`AppliedSensor' or `thecompany'). AppliedSensor is a Swedish/German technology leader in thedevelopment and production of advanced gas sensing solutions to OEMs (OriginalEquipment Manufacturers). The investment values AppliedSensor at approximatelySEK164m (c.‚£12m) and following the closing of this latest fundraising round,Nanoscience will have an interest in the company of approximately 2.91 percent.As previously announced, the Group made its first strategic investment ofapproximately ‚£215,000 in AppliedSensor in June of last year as part of afunding round intended to progress a number of ongoing commercial projects thathad been undertaken by AppliedSensor. Since that time, the company hasdemonstrated to Nanoscience a significant level of continuing technical andcommercial progress which has led to the Board's decision to increase theGroup's investment in the company. The Board is also further encouraged by thecompany's ability to attract new investors at a price c. 33% higher than theprevious investment round completed only one year ago. This progress includes asignificant number of customer commitments to purchase AppliedSensor's productsfor a range of gas sensing solutions within the automotive and otherindustries.In addition, AppliedSensor has an exclusive development and supply agreementwith a leading manufacturer of sensing modules for the supply of air qualitysensors to the automotive industry and is progressing business opportunitiesfor other applications of its platform technology with various industry OEMs.The innovative technology is based on metal-oxide and field-effect technologiesinitially developed at the University of Tubringen, Germany, and the Universityof Linkoping, Sweden. The sensors combine semiconductor and nanotechnologiesresulting in low cost, miniature gas sensing components and modules. Theproduction process includes nano-scale preparation and application of the gassensing material.Richard Rose, Non-Executive Chairman, commented:"Since making our initial investment in AppliedSensor in June of last year wehave closely monitored the progress made by the company and are very happy tohave the opportunity to increase our level of investment.To date, AppliedSensor has made a very satisfying level of commercial progresswhich we believe will take the business to a cash flow positive position in thefourth quarter of next year. The management of the company have been verysuccessful in progressing their commercial relationships with a number ofautomotive OEMs and I look forward to reporting on the progress of the companyas it begins to materialise the value of these relationships over the comingyear. " -Ends- Further Information:Richard Rose Nanoscience Inc. 07836 250 474 Andrew Tan Hansard Communications 020 7245 1100 ENDNANOSCIENCE INC
Date   Source Headline
18th Sep 20157:00 amRNSBlock Listing Interim Review
19th Aug 20157:00 amRNSTotal Voting Rights
3rd Aug 20157:00 amRNSHalf year trading update
13th Jul 20157:00 amRNSSt James's University Hospital trial
10th Jun 20157:00 amRNSCo-development agreement with Google
3rd Jun 201511:16 amRNSBoard change
29th May 20158:00 amRNSTotal Voting Rights
28th May 201510:20 amRNSResult of AGM
28th May 20157:00 amRNSTrading update
30th Apr 20158:00 amRNSTotal Voting Rights
21st Apr 20157:01 amRNSQueen Elizabeth Hospital trials SensiumVitals
21st Apr 20157:00 amRNSFull year results
1st Apr 201510:00 amRNSNotice of Results
19th Mar 20158:00 amRNSBlocklisting Interim Review
3rd Mar 20157:00 amRNSNorth American Healthcare distribution
29th Jan 20157:00 amRNSTrading update
28th Jan 20158:00 amRNSToumaz Employee Long Term Incentive Plan
28th Nov 20148:00 amRNSTotal Voting Rights
25th Sep 20147:00 amRNSHalf Yearly Report
5th Sep 20147:00 amRNSFrontier Silicon launches new digital radio module
4th Sep 20142:00 pmRNSFrontier Silicon supply agreement with Philips
27th Aug 201410:00 amRNSNotice of Results
19th Aug 20148:00 amRNSIssue of Equity
1st Aug 20147:00 amRNSTrading update
31st Jul 20148:00 amRNSTotal Voting Rights
29th Jul 20147:00 amRNSSensium awarded Technology Strategy Board funding
30th Jun 20147:00 amRNSSouth African distribution for SensiumVitals
26th Jun 20148:00 amRNSEmployee Long Term Incentive Plan
23rd May 20144:34 pmRNSResult of AGM
23rd May 20147:00 amRNSTrading Update
20th May 20147:00 amRNSFrontier Silicon gains Digital Tick Mark approval
8th May 20147:00 amRNSMiddle East distribution for SensiumVitals®
28th Apr 201410:00 amRNSIssue of Equity
14th Apr 20147:00 amRNSNew radio chip and module preview
31st Mar 20147:00 amRNSFull year results
26th Mar 20147:00 amRNSSensiumVitals® expands distribution network
24th Mar 20147:00 amRNSPioneer selects Frontier Silicon's technology
7th Mar 20142:42 pmRNSNotice of Results
31st Jan 201410:00 amRNSTotal Voting Rights
17th Jan 20147:00 amRNSYear-end trading update
16th Dec 20137:00 amRNSFrontier Silicon extends Imagination partnership
25th Nov 201310:47 amRNSResult of EGM
25th Nov 20137:00 amRNSVenice module wins industry excellence award
13th Nov 20137:00 amRNSPatrick Hannon elected President of WorldDMB
7th Nov 20137:00 amRNSPlacing
15th Oct 20137:00 amRNSSensiumVitals: CE marking & UK hospital pilot
15th Oct 20137:00 amRNSDistribution agreement: first commercial US orders
23rd Sep 20137:00 amRNSHalf Year Results
9th Sep 20137:00 amRNSSpotify Connect Agreement
5th Sep 201311:20 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.